Apmonia Therapeutics
Signal active
Organization
Contact Information
Overview
Apmonia Therapeutics developing a pipeline of next generation peptide based therapies targeting the tumor microenvironment to improve the lives of patients with cancer. If anyone would want to contact them please contact them via phone call or email.
About
Industries
Biotechnology, Therapeutics
Founded
2019
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Apmonia Therapeutics headquartered in Europe, operates in the Biotechnology, Therapeutics sector. The company focuses on Biotechnology and has secured $506.3M in funding across 32 round(s). With a team of 1-10 employees, Apmonia Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Apmonia Therapeutics, raised $2.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$15.8M
Details
0
Apmonia Therapeutics has raised a total of $15.8M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Apmonia Therapeutics is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Apmonia Therapeutics | - | FUNDING ROUND - Apmonia Therapeutics | 7.7M |
| European Innovation Council | - | FUNDING ROUND - European Innovation Council | 7.7M |
| Apmonia Therapeutics | - | FUNDING ROUND - Apmonia Therapeutics | 2.7M |
| European Innovation Council | - | FUNDING ROUND - European Innovation Council | 2.7M |
Recent Activity
There is no recent news or activity for this profile.